(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ADORATHERAPY

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

ADORATHERAPY

ST13

US500000097175930

Class

3

Filing

97175930

Registration

7416871

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

23

Latest update

12/02/2025

Trademark type

Word

Nice classes

3

Filing date

12/16/2021

Registration date

06/18/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/18/2024

Last transaction

12/02/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

07/31/2016

First use in commerce

07/31/2016

Drawing code

4

Owner type

16

Owner location

ASHEVILLE, NC

Examiner

MATZINGER,AMY L

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

AURATHERAPY LLC
Adoratherapy, Inc.

Representatives

Erica L. Tritt The Sladkus Law Group

Technical classification

Nice Classes

Class 3

Vienna Codes

No Vienna codes available.

Goods and services

Class 3

Perfumes; Essential oils for aromatherapy use; Essential oils for use in the manufacture of scented products

Publications

History of USPTO decisions and trademark events.

23 publications found

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

12/01/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

06/18/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

06/18/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/02/2024

PUBO

PUBLISHED FOR OPPOSITION

04/02/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/13/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/23/2024

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

02/21/2024

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

08/21/2023

GNSL

LETTER OF SUSPENSION E-MAILED

08/21/2023

CNSL

SUSPENSION LETTER WRITTEN

08/21/2023

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

02/21/2023

GNSL

LETTER OF SUSPENSION E-MAILED

02/21/2023

CNSL

SUSPENSION LETTER WRITTEN

02/21/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/30/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/30/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/30/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/23/2022

GNRT

NON-FINAL ACTION E-MAILED

09/23/2022

CNRT

NON-FINAL ACTION WRITTEN

09/23/2022

DOCK

ASSIGNED TO EXAMINER

09/22/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/21/2021

NWAP

NEW APPLICATION ENTERED

12/20/2021

Continuous trademark protection

Get notified about every new filing that threatens ADORATHERAPY or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.